Topical Therapy in Psoriasis

被引：11

作者：

Ahmed, Sk Shahriar ^{[1
]}

Manchanda, Yashpal ^{[2
]}

De, Abhishek ^{[2
]}

Das, Sudip ^{[2
]}

Kumar, Rajesh ^{[3
]}

机构：

[1] Kuwait Univ, Farwaniya Hosp, Dept Dermatol, Kuwait, Kuwait

[2] Calcutta Natl Med Coll, Dept Dermatol, Kolkata, W Bengal, India

[3] Grant Med Coll, Dermatol, Kolkata, India

来源：

INDIAN JOURNAL OF DERMATOLOGY | 2023年 / 68卷 / 04期

关键词：

Psoriasis; symposium; Topical medicines; HALOBETASOL PROPIONATE OINTMENT; DOUBLE-BLIND; PLAQUE PSORIASIS; SHORT-CONTACT; SALICYLIC-ACID; COAL-TAR; 0.1-PERCENT BETAMETHASONE; PERCUTANEOUS-ABSORPTION; CALCIPOTRIENE OINTMENT; MULTICENTER TRIAL;

D O I：

10.4103/ijd.ijd_422_23

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Psoriasis is a chronic condition that progresses in remitting and relapsing phases. Most of these patients have mild-to-moderate illness, which can be managed with topical medications or could be thought of as continuing therapy after remission. Potential therapeutic efficacy is offered, and systemic treatment's negative side effects are constrained. Topical therapies have recently advanced in tandem with recent advancements in our understanding of psoriasis. To improve the quality of life of patients, appropriate knowledge and application of these topical agents are crucial.

引用

页码：437 / 445

页数：9

共 81 条

[61] Drug delivery and formulations for the topical treatment of psoriasis [J].

Su, Yu-Han ;

Fang, Jia-You .

EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (02) :235-249

[62] INTERMITTENT TOPICAL TREATMENT OF PSORIASIS WITH CLOBETASOL PROPIONATE (DERMOVATE) [J].

SVARTHOLM, H ;

LARSSON, L ;

FREDERIKSEN, B .

CURRENT MEDICAL RESEARCH AND OPINION, 1982, 8 (03) :154-157

[63] Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation [J].

Takahashi, H ;

Ibe, M ;

Kinouchi, M ;

Ishida-Yamamoto, A ;

Hashimoto, Y ;

Iizuka, H .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2003, 31 (01) :21-28

[64] Psoriasis and pregnancy [J].

Tauscher, AE ;

Fleischer, AB ;

Phelps, KC ;

Feldman, SR .

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2002, 6 (06) :561-570

[65] Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris [J].

Tiplica, G-S ;

Salavastru, C. M. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (08) :905-912

[66] Small Molecules in the Treatment of Psoriasis [J].

Torres, Tiago ;

Filipe, Paulo .

DRUG DEVELOPMENT RESEARCH, 2015, 76 (05) :215-227

[67] Psoriasis: consensus on topical therapies [J].

van de Kerkhof, P. C. M. ;

Barker, J. ;

Griffths, C. E. M. ;

Kragballe, K. ;

Mason, J. ;

Menter, A. ;

Papp, K. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (07) :859-870

[68] The topical treatment of psoriasis [J].

van de Kerkhof, PCM ;

Vissers, WHPM .

SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2003, 16 (02) :69-83

[69] Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis [J].

van de Kerkhof, PCM ;

Berth-Jones, J ;

Griffiths, CEM ;

Harrison, PV ;

Hönigsmann, H ;

Marks, R ;

Roelandts, R ;

Schöpf, E ;

Trompke, C .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (03) :414-422

[70] Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial [J].

Veien, NK ;

Bjerke, JR ;

RossmannRingdahl, I ;

Jakobsen, HB .

BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (04) :581-586

← 1 2 3 4 5 6 7 8 9 →